Filing metadata

Accession number
0001714899-22-000109
Form type
Form 4
Filer
Denali Therapeutics Inc.
CIK
CIK 1714899
Filed
Jul 27, 2022
Reporting period
Jul 25, 2022
Description
Insider transaction

Explore SEC Filings Hub